 Difluoromethylornithine therapy female NZB/W mice effects difluoromethylornithine DFMO experimental drug biosynthesis natural polyamines anti-DNA antibody production immunoglobulin synthesis proteinuria blood urea nitrogen BUN lupus-prone female NZB/W mice Administration drug drinking water anti-DNA antibody levels untreated mice strain reduction IgG IgA levels DFMO mice whereas IgM level Proteinuria BUN treated mice DFMO treatment concentration putrescine spermidine spleen cells results polyamine biosynthesis inhibition DFMO new approach treatment lupus